Companies / Akebia Therapeutics, Inc. / Activity
Activity — Akebia Therapeutics, Inc.
62 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $761.4K | +668K +3.46% | 19,986,374 7.21% of shares | low |
| Q1 2026 as of | Los Angeles Capital Management LLC 13F manager | Add | Common stock | $794.7K | +572K +1930.97% | 601,308 0.22% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | Common stock | $1.02M | +731K +44.22% | 2,384,713 0.86% of shares | low |
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Exit | Common stock | $-1.13M | -704K -100.00% | 0 | low |
| Q1 2026 as of | Nordea Investment Management AB 13F manager | Exit | Common stock | $-1.21M | -752K -100.00% | 0 | low |
| Q1 2026 as of | First Trust Advisors LP 13F manager | Exit | Common stock | $-1.52M | -942K -100.00% | 0 | low |
| Q1 2026 as of | AQR Capital Management, LLC 13F manager | Add | Common stock | $1.59M | +1.1M +177.20% | 1,792,620 0.65% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | Common stock | $1.68M | +1.2M +1332.15% | 1,297,801 0.47% of shares | low |
| Q1 2026 as of | Federated Hermes Inc 13F manager | Exit | Common stock | $-2.08M | -1.3M -100.00% | 0 | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Trim | Common stock | $-2.45M | -1.8M -48.98% | 1,833,128 0.66% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | Add | Common stock | $2.46M | +676K +219.51% | 984,512 0.36% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Trim | Common stock | $-9.46M | -8.3M -60.61% | 5,390,853 1.95% of shares | medium |